Norges Bank’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $77M | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $98.9M | Buy |
|
|||||
|
2024
Q3 | $104M | Buy |
|
|||||
|
2024
Q2 | $106M | Buy |
|
|||||
|
2024
Q1 | $124M | Buy |
|
|||||
|
2023
Q4 | $101M | Buy |
|
|||||
|
2023
Q3 | $72.3M | Sell |
|
|||||
|
2023
Q2 | $80.6M | Sell |
|
|||||
|
2023
Q1 | $96M | Buy |
|
|||||
|
2022
Q4 | $97.7M | Sell |
|
|||||
|
2022
Q3 | $92.3M | Sell |
|
|||||
|
2022
Q2 | $103M | Sell |
|
|||||
|
2022
Q1 | $139M | Sell |
|
|||||
|
2021
Q4 | $191M | Buy |
|
|||||
|
2021
Q3 | $203M | Sell |
|
|||||
|
2021
Q2 | $189M | Buy |
|
|||||
|
2021
Q1 | $143M | Buy |
|
|||||
|
2020
Q4 | $121M | Hold |
|
|||||
|
2020
Q3 | $109M | Sell |
|
|||||
|
2020
Q2 | $85.6M | Sell |
|
|||||
|
2020
Q1 | $65.5M | Buy |
|
|||||
|
2019
Q4 | $78.6M | Hold |
|
|||||
|
2019
Q3 | $68.2M | Buy |
|
|||||
|
2019
Q2 | $72.2M | Sell |
|
|||||
|
2019
Q1 | $78.2M | Sell |
|
|||||
|
2018
Q4 | $61.5M | Buy |
|
|||||
|
2018
Q3 | $69.3M | Hold |
|
|||||
|
2018
Q2 | $57.8M | Hold |
|
|||||
|
2018
Q1 | $55M | Hold |
|
|||||
|
2017
Q4 | $56.4M | Hold |
|
|||||
|
2017
Q3 | $55.6M | Sell |
|
|||||
|
2017
Q2 | $72M | Buy |
|
|||||
|
2017
Q1 | $61.2M | Sell |
|
|||||
|
2016
Q4 | $53M | Buy |
|
|||||
|
2016
Q3 | $54.2M | Buy |
|
|||||
|
2016
Q2 | $51M | Hold |
|
|||||
|
2016
Q1 | $46.9M | Hold |
|
|||||
|
2015
Q4 | $49.7M | Buy |
|
|||||
|
2015
Q3 | $38M | Hold |
|
|||||
|
2015
Q2 | $42M | Hold |
|
|||||
|
2015
Q1 | $47.4M | Hold |
|
|||||
|
2014
Q4 | $38M | Buy |
|
|||||
|
2014
Q3 | $27.5M | Sell |
|
|||||
|
2014
Q2 | $43.7M | Buy |
|
|||||
|
2014
Q1 | $19.8M | Hold |
|
|||||
|
2013
Q4 | $17.4M | Hold |
|
|||||
|
2013
Q3 | $15.2M | Buy |
|
|||||
|
2013
Q2 | $11.5M | Buy |
|